title: [Experimental substantiation of recombinant epidermal growth factor use efficacy in the treatment of wounds of mucosal membrane of oral cavity in the immunodeficiency].
abstract: In experiment on rats in the immunodeficiency the use of recombinant epidermal growth factor was substantiated that let to speed up reparative regeneration at concentration 500 ppb/l drinking water.
authors.forename: A I
authors.initials: AI
authors.lastname: Volozhin
authors.forename: V V
authors.initials: VV
authors.lastname: Gemonov
authors.forename: D V
authors.initials: DV
authors.lastname: Kabaloeva
authors.forename: B Iu
authors.initials: BIu
authors.lastname: Surazhev
mesh_terms: D000818:Animals; D017074:Common Variable Immunodeficiency; D004815:Epidermal Growth Factor / Q000627:therapeutic use*; D009055:Mouth / Q000187:drug effects* / Q000293:injuries*; D009092:Mucous Membrane / Q000187:drug effects / Q000293:injuries; D051381:Rats; D017208:Rats, Wistar; D011994:Recombinant Proteins / Q000627:therapeutic use*; D014945:Wound Healing / Q000187:drug effects*
chemical_list: D011994:Recombinant Proteins; D004815:Epidermal Growth Factor